Clinical Trial Update: A PhaseⅠ Study of HW252001 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase I trial update for HW252001 in healthy subjects, with idiopathic pulmonary fibrosis listed as a condition and recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• HW252001

Snippet

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Conditions: IPF | Phase 1 | Status: NOT_YET_RECRUITING